<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="int-interactant" /><meta name="keywords" content="" /><title>Phenindione: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="41001i223.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="41001i223.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=41001i223.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="41001.htm">Appendix 1 Interactions</a> &gt; <a href="53178.htm">List of drug interactions</a> &gt; <a href="41001i219.htm">Anticoagulants</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="41001i222.htm" title="Previous: Warfarin">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="41001i224.htm" title="Next: Heparins">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_41001i223">Phenindione</h1><div id="pC" class="jN"><p class="int-specific-drug-name"><b>Phenindione</b>
          has the following interaction information:
        </p><div>Change in patient’s clinical condition particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control  </div><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cBT" /><col width="40%" class="cBS" /><col width="30%" class="cBU" /></colgroup><tbody><tr><td><a href="41001i20.htm" name="_20">Alcohol</a></td><td class="cBV"><b>anticoagulant control with  phenindione may be affected by major changes in consumption of alcohol </b></td><td></td></tr><tr><td><a href="41001i118.htm">Amiodarone</a></td><td class="cBV"><b>metabolism of  phenindione inhibited by amiodarone (enhanced anticoagulant effect)</b></td><td>Amiodarone has a long half-life; there is a potential for drug interactions to occur for several weeks (or even months) after treatment with it has been stopped</td></tr><tr><td><a href="41001i36.htm">Anabolic Steroids</a></td><td class="cBV"><b>anticoagulant effect of  phenindione enhanced by anabolic steroids </b></td><td></td></tr><tr><td><a href="41001i361.htm" name="_361">Aspirin</a></td><td class="cBV"><b>increased risk of bleeding when  phenindione given with aspirin (due to antiplatelet effect)</b></td><td></td></tr><tr><td><a href="41001i865.htm">Clopidogrel</a></td><td class="cBV"><b>anticoagulant effect of  phenindione enhanced due to antiplatelet action of clopidogrel </b></td><td></td></tr><tr><td><a href="41001i592.htm">Colestyramine</a></td><td class="cBV"><b>anticoagulant effect of  phenindione may be enhanced or reduced by colestyramine </b></td><td>Other drugs should be taken at least 1 hour before or 4–6 hours after colestyramine to reduce possible interference with absorption</td></tr><tr><td><a href="41001i484.htm">Corticosteroids</a></td><td>anticoagulant effect of  phenindione may be enhanced or reduced by corticosteroids </td><td>Interactions do not generally apply to corticosteroids used for topical action (including inhalation) unless specified</td></tr><tr><td><a href="41001i362.htm">Dipyridamole</a></td><td class="cBV"><b>anticoagulant effect of  phenindione enhanced due to antiplatelet action of dipyridamole </b></td><td></td></tr><tr><td><a href="41001i1176.htm">Dronedarone</a></td><td class="cBV"><b>anticoagulant effect of  phenindione possibly enhanced by dronedarone </b></td><td></td></tr><tr><td><a href="41001i830.htm">Enteral Foods</a></td><td class="cBV"><b>anticoagulant effect of  phenindione antagonised by vitamin K (present in some enteral feeds )</b></td><td></td></tr><tr><td><a href="41001i594.htm">Fibrates</a></td><td class="cBV"><b>anticoagulant effect of  phenindione enhanced by fibrates </b></td><td></td></tr><tr><td><a href="41001i1015.htm" name="_1015">Iloprost</a></td><td>increased risk of bleeding when  phenindione given with iloprost </td><td></td></tr><tr><td><a href="41001i840.htm">Levofloxacin</a></td><td>anticoagulant effect of  phenindione possibly enhanced by levofloxacin </td><td></td></tr><tr><td><a href="41001i133.htm" name="_133">Neomycin</a></td><td class="cBV"><b>experience in anticoagulant clinics suggests that INR possibly altered when  phenindione is given with neomycin (given for local action on gut)</b></td><td></td></tr><tr><td><a href="41001i60.htm">NSAIDs</a></td><td class="cBV"><b>anticoagulant effect of  phenindione possibly enhanced by NSAIDs </b></td><td><i>See also </i>Aspirin. Interactions do not generally apply to topical NSAIDs
</td></tr><tr><td><a href="41001i636.htm">Oestrogens</a></td><td class="cBV"><b>anticoagulant effect of  phenindione antagonised by oestrogens </b></td><td>Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a title="COCs interactions (target-block)" href="4552.htm#_120026">section 7.3.1</a></td></tr><tr><td><a href="41001i174.htm">Penicillins</a></td><td>an interaction between  phenindione and broad-spectrum penicillins has not been demonstrated in studies, but common experience in anticoagulant clinics is that INR can be altered</td><td></td></tr><tr><td><a href="41001i1146.htm" name="_1146">Prasugrel</a></td><td>possible increased risk of bleeding when  phenindione given with prasugrel </td><td></td></tr><tr><td><a href="41001i664.htm">Progestogens</a></td><td class="cBV"><b>anticoagulant effect of  phenindione antagonised by progestogens </b></td><td>Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a title="" href="4552.htm#_120026">section 7.3.1</a>. For further information on interactions of oral progestogen-only contraceptives, see also <a title="" href="4572.htm#_4572.2">section 7.3.2.1</a>; parenteral progestogen-only contraceptives, see also <a title="" href="4580.htm#_4580.4">section 7.3.2.2</a>; the intra-uterine progestogen-only device, see also <a title="" href="31947.htm#_31947.1">section 7.3.2.3</a>; hormonal emergency contraception, see also <a title="" href="130057.htm#_100043.3">section 7.3.5</a></td></tr><tr><td><a href="41001i400.htm">Ritonavir</a></td><td class="cBV"><b>anticoagulant effect of  phenindione possibly enhanced by ritonavir </b></td><td></td></tr><tr><td><a href="41001i974.htm">Rosuvastatin</a></td><td class="cBV"><b>anticoagulant effect of  phenindione possibly enhanced by rosuvastatin </b></td><td></td></tr><tr><td><a href="41001i203.htm">Sulfonamides</a></td><td>metabolism of  phenindione possibly inhibited by sulfonamides </td><td></td></tr><tr><td><a href="41001i1035.htm">Testolactone</a></td><td class="cBV"><b>anticoagulant effect of  phenindione enhanced by testolactone </b></td><td></td></tr><tr><td><a href="41001i814.htm">Testosterone</a></td><td class="cBV"><b>anticoagulant effect of  phenindione enhanced by testosterone </b></td><td></td></tr><tr><td><a href="41001i209.htm">Tetracyclines</a></td><td class="cBV"><b>anticoagulant effect of  phenindione possibly enhanced by tetracyclines </b></td><td></td></tr><tr><td><a href="41001i935.htm">Thyroid Hormones</a></td><td class="cBV"><b>anticoagulant effect of  phenindione enhanced by thyroid hormones </b></td><td></td></tr><tr><td><a href="41001i769.htm">Vitamin K (Phytomenadione)</a></td><td class="cBV"><b>anticoagulant effect of  phenindione antagonised by vitamin K </b></td><td></td></tr></tbody></table><p>Phenindione belongs to <b>Anticoagulants</b>
          and will have the following interactions:
        </p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cBT" /><col width="40%" class="cBS" /><col width="30%" class="cBU" /></colgroup><tbody>


<tr><td><a href="41001i64.htm">Diclofenac</a></td><td class="cBV"><b>increased risk of haemorrhage when  anticoagulants given with <i>intravenous</i> diclofenac (avoid concomitant use, including low-dose heparins)</b></td><td></td></tr><tr><td><a href="41001i72.htm">Ketorolac</a></td><td class="cBV"><b>increased risk of haemorrhage when  anticoagulants given with ketorolac (avoid concomitant use, including low-dose heparins)</b></td><td></td></tr></tbody></table></div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="41001i222.htm">Previous: Warfarin</a> | <a class="top" href="41001i223.htm#">Top</a> | <a accesskey="]" href="41001i224.htm">Next: Heparins</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>